Alain Paris

Prof. Alain Paris


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BSBenoît Sotton
Benoît Sotton
APAlain Paris
Alain Paris
SMSéverine Le Manach
Séverine Le Manach
ABAlain Blond
Alain Blond
GLGérard Lacroix
Gérard Lacroix
BMBenjamin Marie
Benjamin Marie
Cyanobacterial blooms pose serious threats to aquatic organisms and strongly impact the functioning of aquatic ecosystems. Due to their ability to produce a wide range of potentially bioactive secondary metabolites, so called cyanotoxins, cyanobacteria have been extensively studied in the past decades. Proteomic and metabolomic analyses provide a unique opportunity to evaluate the global response of hundreds of proteins and metabolites at a glance. In this study, we provide the first combined utilization of these methods targeted to identify the response of fish to bloom-forming cyanobacteria. Medaka fish (Oryzias latipes) were exposed for 96 hours either to a MC-producing or to a non-MC-producing strain of Microcystis aeruginosa and cellular, proteome and metabolome changes following exposure to cyanobacteria were characterized in the fish livers. The results suggest that a short-term exposure to cyanobacteria, producing or not MCs, induces sex-dependent molecular changes in medaka fish, without causing any cellular alterations. Globally, molecular entities involved in stress response, lipid metabolism and developmental processes exhibit the most contrasted changes following a cyanobacterial exposure. Moreover, it appears that proteomic and metabolomic analyses are useful tools to verify previous information and to additionally bring new horizons concerning molecular effects of cyanobacteria on fish.

1 May 2000 in Analusis
Verified
Journal Article
Open access
PDF file
EREstelle Rathahao-Paris
Estelle Rathahao-Paris
AHA. Hillenweck
A. Hillenweck
APAlain Paris
Alain Paris
DLDebrauwer Laurent
Debrauwer Laurent

5 May 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
NBNihel Bekhti
Nihel Bekhti
FCFlorence Castelli
Florence Castelli
APAlain Paris
Alain Paris
BGBlanche Guillon
Blanche Guillon
CJChristophe Junot
Christophe Junot
KAKarine Adel-Patient
Karine Adel-Patient
Meconium represents the first newborn stools, formed from the second month of gestation and excreted in the first days after birth. As an accumulative and inert matrix, it accumulates most of the molecules transferred through the placenta from the mother to the fetus during the last 6 months of pregnancy, and those resulting from the metabolic activities of the fetus. To date, only few studies dealing with meconium metabolomics have been published. In this study, we aimed to provide a comprehensive view of the meconium metabolic composition using 33 samples collected longitudinally from 11 healthy newborns and to analyze its evolution during the first 3 days of life. First, a robust and efficient methodology for metabolite extraction was implemented. Data acquisition was performed using liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS), using two complementary LC-HRMS conditions. Data preprocessing and treatment were performed using the Workflow4Metabolomics platform and the metabolite annotation was performed using our in-house database by matching accurate masses, retention times, and MS/MS spectra to those of pure standards. We successfully identified up to 229 metabolites at a high confidence level in human meconium, belonging to diverse chemical classes and from different origins. A progressive evolution of the metabolic profile was statistically evidenced, with sugars, amino acids, and some bacteria-derived metabolites being among the most impacted identified compounds. Our implemented analytical workflow allows a unique and comprehensive description of the meconium metabolome, which is related to factors, such as maternal diet and environment.

1 October 2010 in Steroids
Verified
Journal Article
Closed access
DBDelphine Bellocq
Delphine Bellocq
JMJérôme Molina
Jérôme Molina
EREstelle Rathahao-Paris
Estelle Rathahao-Paris
STSylviane Taché
Sylviane Taché
FPFabrice Pierre
Fabrice Pierre
APAlain Paris
Alain Paris

6 July 2021 in Metabolomics
Verified
Journal Article
Open access
PDF file
APAlain Paris
Alain Paris
BLBoris Labrador
Boris Labrador
FLFrançois-Xavier LEJEUNE
François-Xavier LEJEUNE
CCCécile Canlet
Cécile Canlet
JMJérôme Molina
Jérôme Molina
YBYves Le Bouc
Yves Le Bouc
Introduction Serum phenotyping of elite cyclists regarding cortisol, IGF1 and testosterone is a way to detect endocrine disruptions possibly explained by exercise overload, non-balanced diet or by doping. This latter disruption-driven approach is supported by fundamental physiology although without any evidence of any metabolic markers. Objectives Serum samples were distributed through Low, High or Normal endocrine classes according to hormone concentration. A 1H NMR metabolomic study of 655 serum obtained in the context of the longitudinal medical follow-up of 253 subjects was performed to discriminate the three classes for every endocrine phenotype. Methods An original processing algorithm was built which combined a partial-least squares-based orthogonal correction of metabolomic signals and a shrinkage discriminant analysis (SDA) to get satisfying classifications. An extended validation procedure was used to plan in larger size cohorts a minimal size to get a global prediction rate (GPR), i.e. the product of the three class prediction rates, higher than 99.9%. Results Considering the 200 most SDA-informative variables, a sigmoidal fitting of the GPR gave estimates of a minimal sample size to 929, 2346 and 1408 for cortisol, IGF1 and testosterone, respectively. Analysis of outliers from cortisol and testosterone Normal classes outside the 97.5%-confidence limit of score prediction revealed possibly (i) an inadequate protein intake for outliers or (ii) an intake of dietary ergogenics, glycine or glutamine, which might explain the significant presence of heterogeneous metabolic profiles in a supposedly normal cyclists subgroup. Conclusion In a next validation metabolomics study of a so-sized cohort, anthropological, clinical and dietary metadata should be recorded in priority at the blood collection time to confirm these functional hypotheses.

15 March 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
GLGaëlle Lefort
Gaëlle Lefort
RSRémi Servien
Rémi Servien
HQHélène Quesnel
Hélène Quesnel
YBYvon Billon
Yvon Billon
LCLaurianne Canario
Laurianne Canario
LLLaurence Liaubet
Laurence Liaubet
In mammalian species, the first days after birth are an important period for survival and the rates of mortality before weaning are high. In pigs, the perinatal deaths average 20% of the litter, with important economic and societal consequences. Among the factors influencing piglet survival at birth, the maturity is likely to be one of the most important. Maturity can be defined as the outcome of complex mechanisms of intra-uterine development and maturation occurring during the last month of gestation. Here, we provide new insights on maturity by studying the end of gestation at two different stages (three weeks before term and close to term) in two breeds of pigs that strongly differ in terms of neonatal survival. Since metabolomics is a promising approach for phenotype characterization or biomarker discovery, we provide a complete understanding of the metabolome of the fetuses in late gestation in three fluids (plasma, urine, and amniotic fluid). We found that biological processes related to amino acid and carbohy-drate metabolisms are critical for piglet maturity. We also confirmed some previously described metabolites associated with delayed growth ( e.g. , proline and myo-inositol). Altogether, our study proposes new routes for a better characterization of piglet maturity at birth.